A detailed history of One Ascent Financial Services LLC transactions in Amgen Inc stock. As of the latest transaction made, One Ascent Financial Services LLC holds 879 shares of AMGN stock, worth $277,764. This represents 0.04% of its overall portfolio holdings.

Number of Shares
879
Previous 988 11.03%
Holding current value
$277,764
Previous $281,000 2.14%
% of portfolio
0.04%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$262.75 - $319.31 $28,639 - $34,804
-109 Reduced 11.03%
879 $275,000
Q1 2024

Apr 16, 2024

SELL
$268.87 - $324.56 $257,308 - $310,603
-957 Reduced 49.2%
988 $281,000
Q4 2023

Jan 11, 2024

BUY
$255.7 - $288.46 $250,330 - $282,402
979 Added 101.35%
1,945 $560,000
Q3 2023

Oct 13, 2023

BUY
$218.65 - $271.46 $211,215 - $262,230
966 New
966 $260,000
Q2 2022

Aug 08, 2022

BUY
$230.71 - $256.74 $250,320 - $278,562
1,085 New
1,085 $264,000
Q1 2021

Apr 27, 2021

SELL
$221.91 - $258.6 $494,637 - $576,419
-2,229 Closed
0 $0
Q4 2020

Feb 08, 2021

SELL
$216.38 - $257.67 $555,447 - $661,438
-2,567 Reduced 53.52%
2,229 $513,000
Q4 2020

Jan 13, 2021

BUY
$216.38 - $257.67 $123,769 - $147,387
572 Added 13.54%
4,796 $1.1 Million
Q3 2020

Nov 02, 2020

BUY
$234.65 - $260.95 $75,088 - $83,504
320 Added 8.2%
4,224 $1.07 Million
Q2 2020

Jul 21, 2020

BUY
$197.81 - $242.74 $105,037 - $128,894
531 Added 15.74%
3,904 $921,000
Q1 2020

Apr 14, 2020

SELL
$182.24 - $241.7 $101,507 - $134,626
-557 Reduced 14.17%
3,373 $684,000
Q4 2019

Feb 11, 2020

BUY
$189.21 - $243.2 $743,595 - $955,776
3,930 New
3,930 $947,000
Q3 2019

Nov 15, 2019

SELL
$174.11 - $208.62 $761,731 - $912,712
-4,375 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$166.7 - $195.41 $729,312 - $854,918
4,375 New
4,375 $806,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track One Ascent Financial Services LLC Portfolio

Follow One Ascent Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One Ascent Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on One Ascent Financial Services LLC with notifications on news.